MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517070792 A) filed by Floating Knight Biotech Pte. Ltd., Singapore, on July 25, for 'mannuronate, guluronate and gulumannuronate tablet, capsule or ampoule formulation and method for its preparation.'
Inventor(s) include Mirshafiey, Abbas; and Lalander, Jacob.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to tablet, capsule and ampoule formulations for oral and/or injectable use, the formulation comprising -D-mannuronic acid or a-L-guluronic acid or a mixture of -D- mannuronic acid and a-L-guluronic acid, oli...